As the federal trial of the New England Compounding Center (NECC) continues, Keith Hasson was quoted in Pain Medicine News on Feb. 16, 2017, discussing the ongoing crackdown compounding pharmacies face from the Drug Quality and Security Act.
A recent report from the FDA stated that the administration has issued more than 130 warning letters to compounders over federal violations and overseen about 100 recalls since the law went into effect in 2012. Hasson notes that the report “reads like a document trying to justify (the FDA’s) efforts in the compounding pharmacy space, and they make a pretty good case.” For the full article, please click here.